All logins are passed through a 256 bit (AES-256) SSL certificate. Even if you don't see the https:// link, please rest assured that it is being used. If you prefer, you can login via a page where the certificate is "visible":
Community Menu
PDFProject 1 - Reversal Potential of Tubulointerstitial Fibrosis
This page document is being viewed within the PCEN Projects collection.
Last modified on January 23, 2012 at 1:26 PM by Dominique Brand
Summary description:
Summary description:
Project Leader: Agnes B. Fogo, M.D.
Co-Investigator: Li-Jun Ma, M.D., Ph.D.
Consultant: Leslie Gewin, M.D.
Kidney scarring causes loss of kidney function. New insights into approaches to decrease scarring are needed, as current approaches do not stop ongoing scarring and end stage kidney disease. We have found that thymosin β4 decreases scarring in late stages of injury. We will now determine the specific cells and mechanisms, and potential for reversal of scarring with treatment with thymosin β4.
